These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1650767)

  • 1. Monoclonal antibodies for radioimmunoscintigraphy of breast cancer.
    Merino MJ; Monteagudo C; Neumann RD
    Int J Rad Appl Instrum B; 1991; 18(4):437-43. PubMed ID: 1650767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical applications of monoclonal antibodies against ovarian cancer-associated antigens.
    Kenemans P; Yedema CA; Hilgers JH; Massuger LF; Verheijen RH; Thomas CM; Poels LG
    Eur J Obstet Gynecol Reprod Biol; 1988 Nov; 29(3):207-18. PubMed ID: 3065097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Monoclonal antibodies in the diagnosis of breast carcinoma].
    Beketić-Oresković L; Novak D
    Lijec Vjesn; 1992; 114(5-8):157-60. PubMed ID: 1343051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelial Tie growth factor receptor provides antigenic marker for assessment of breast cancer angiogenesis.
    Salvén P; Joensuu H; Heikkilä P; Matikainen MT; Wasenius VM; Alanko A; Alitalo K
    Br J Cancer; 1996 Jul; 74(1):69-72. PubMed ID: 8679461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selection of tumor-specific epitopes on target antigens for radioimmunotherapy of breast cancer.
    Peterson JA; Couto JR; Taylor MR; Ceriani RL
    Cancer Res; 1995 Dec; 55(23 Suppl):5847s-5851s. PubMed ID: 7493358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of monoclonal antibodies showing a different spectrum of reactivity to human breast tissue.
    Mandeville R; Giroux L; Lecomte J; Chausseau JP; Dumas F; Ajdukovic I; Vidal D; Boury F
    Cancer Detect Prev; 1987; 10(1-2):89-100. PubMed ID: 2436777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human breast cancer markers].
    Remennik LV
    Eksp Onkol; 1985; 7(4):3-8. PubMed ID: 2994992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monoclonal antibodies to antigens abnormally expressed in breast cancer.
    Major PP; Kovac PE; Lavallée ML; Kovalik EC
    J Histochem Cytochem; 1987 Feb; 35(2):139-48. PubMed ID: 3540102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 variant exon epitopes in primary breast cancer and length of survival.
    Kaufmann M; Heider KH; Sinn HP; von Minckwitz G; Ponta H; Herrlich P
    Lancet; 1995 Mar; 345(8950):615-9. PubMed ID: 7534855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the CD44 glycoprotein (lymphocyte-homing receptor) in untreated human breast cancer and its relationship to prognostic markers.
    de la Torre M; Heldin P; Bergh J
    Anticancer Res; 1995; 15(6B):2791-5. PubMed ID: 8669866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a monoclonal antibody against human prolactin receptors.
    Banerjee R; Ginsburg E; Vonderhaar BK
    Int J Cancer; 1993 Nov; 55(5):712-21. PubMed ID: 7503956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibodies against human milk-fat globule membranes detecting differentiation antigens of the mammary gland and its tumors.
    Hilkens J; Buijs F; Hilgers J; Hageman P; Calafat J; Sonnenberg A; van der Valk M
    Int J Cancer; 1984 Aug; 34(2):197-206. PubMed ID: 6206003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibodies: old and new trends in breast cancer imaging and therapeutic approach.
    Stipsanelli E; Valsamaki P
    Hell J Nucl Med; 2005; 8(2):103-8. PubMed ID: 16142251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demonstration with monoclonal antibodies of an unusual mononuclear cell infiltrate and loss of normal epithelial membrane antigens in human breast carcinomas.
    Daar AS; Fabre JW
    Lancet; 1981 Aug; 2(8244):434-8. PubMed ID: 6167828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the tumour-associated antigens recognized by the monoclonal antibodies HMFG-1 and 2 in serum from patients with breast cancer.
    Burchell J; Wang D; Taylor-Papadimitriou J
    Int J Cancer; 1984 Dec; 34(6):763-8. PubMed ID: 6210253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The story of hormone receptor assays: why are we still searching?
    Masood S
    Breast J; 2001; 7(4):205-6. PubMed ID: 11678795
    [No Abstract]   [Full Text] [Related]  

  • 17. Radioimmunolocalization of primary and metastatic breast cancer.
    Baum RP; Brümmendorf TH
    Q J Nucl Med; 1998 Mar; 42(1):33-42. PubMed ID: 9646643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunocytochemical identification of cell types in benign and malignant breast diseases: variations in cell markers accompany the malignant state.
    Rudland PS; Leinster SJ; Winstanley J; Green B; Atkinson M; Zakhour HD
    J Histochem Cytochem; 1993 Apr; 41(4):543-53. PubMed ID: 8450194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast tumor radioimmunodetection with a 111In-labeled monoclonal antibody (MA5) against a mucin-like antigen.
    Major PP; Dion AS; Williams CJ; Mattes MJ; Wang T; Rosenthall L
    Cancer Res; 1990 Feb; 50(3 Suppl):927s-931s. PubMed ID: 2297743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal epithelial antigens recognized by GB3 and GB5 are diminished in intraductal and lost in infiltrating human breast carcinomas.
    Yeh CJ; Hsi BL; Ettore F
    Breast Cancer Res Treat; 1986; 8(2):117-23. PubMed ID: 3028540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.